Ilika targets commercial traction through Brompton e-bike battery programme

Ilika Plc

Ilika has moved its solid-state battery technology into a more commercially relevant stage with a £214,000 development programme alongside Brompton Bicycles. The 12-month project will test Ilika’s 10Ah Goliath batteries in packs for Brompton’s next generation of electric folding bikes, with battery pack production and bike trials planned for mid-2027 if development targets are met.

This is not a large contract, but it is a practical test of whether Ilika’s technology can perform in a real product with a recognised manufacturer. That matters because battery companies need more than technical promise. They need proof that customers can use the product in applications where performance, safety and design constraints all matter.

Folding e-bikes are highly sensitive to battery size, weight and safety, so they provide a useful test case for Goliath. If Ilika’s cells can help reduce weight while maintaining safety and energy performance, that strengthens the company’s case in mobility markets where those factors directly affect product appeal and regulatory acceptance.

Concerns around battery fires have become harder to ignore across the e-bike market, creating a clearer commercial opening for technologies that can offer a safer alternative. Ilika is using this programme to show that solid-state batteries are not simply an improvement in theory, but a possible answer to a visible market problem.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika completes PRIMED programme with improved Goliath battery performance

Ilika has completed its £3 million PRIMED programme, reporting improved energy density, charging, power, cycle life and thermal stability for its 10Ah Goliath solid-state battery cells, alongside new commercial opportunities in defence, e-bikes and other applications.

Ilika to present UK-developed quasi-solid-state cell technology at Faraday Event

Ilika will present its UK-developed quasi-solid-state cell technology at The Faraday Institution’s Next Frontiers in Energy Storage event on Tuesday 8 September.

Ilika targets MedTech adoption with Stereax solid-state batteries

Ilika is targeting medical device and IoT applications with its Stereax miniature solid-state batteries, supported by a manufacturing and commercialisation agreement with Cirtec Medical.

Ilika confirms AGM date and Annual Report posting

Ilika has given notice of its 2026 Annual General Meeting and said its annual report and AGM notice will be available shortly.

Ilika targets medical device opportunities with Stereax at MedTech Ireland

Ilika’s Stereax technology will be presented at MedTech Ireland 2026 as the company targets further opportunities in active implanted medical devices.

Ilika advances Goliath towards commercial deployment

Ilika is advancing Goliath through testing and manufacturing scale-up while targeting shorter-cycle markets alongside longer-term electric vehicle adoption.

Search